Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats
Eun‐Jung Park, You‐Suk Lee, Sung Min Kim, et al.
Nutrients (2020) Vol. 12, Iss. 2, pp. 542-542
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5214-5214
Open Access | Times Cited: 232
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 640-640
Open Access | Times Cited: 41
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Han, Yi Jiang, Mengyu Wang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 12, pp. 1689-1706
Closed Access | Times Cited: 87
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan, Zitong Ding, Muhammad Ishaq, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 818-833
Open Access | Times Cited: 83
Intestinal dysbiosis mediates cognitive impairment via the intestine and brain NLRP3 inflammasome activation in chronic sleep deprivation
Na Zhao, Qiu-Gu Chen, Chen Xiu, et al.
Brain Behavior and Immunity (2022) Vol. 108, pp. 98-117
Closed Access | Times Cited: 36
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 550-550
Open Access | Times Cited: 31
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 662-662
Open Access | Times Cited: 17
Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats
Laura Arellano-García, Jenifer Trepiana, J. Alfredo Martínéz, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 717-717
Open Access | Times Cited: 16
Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2827-2827
Open Access | Times Cited: 24
Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models
Laura Arellano-García, María P. Portillo, J. Alfredo Martínéz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3167-3167
Open Access | Times Cited: 22
Modulatory effects of Lactiplantibacillus plantarum on chronic metabolic diseases
Lei Tian, Ruixiang Zhao, Xinyi Xu, et al.
Food Science and Human Wellness (2022) Vol. 12, Iss. 4, pp. 959-974
Open Access | Times Cited: 22
Current, emerging, and potential therapies for non-alcoholic steatohepatitis
Zhen Yang, Lin Wang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production
Dong Yun Kim, Jun Yong Park, Heon Yung Gee
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2332-2345
Open Access | Times Cited: 14
Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial
Yufeng Jin, Xin Wang, Ke Chen, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD
André A. Santos, Raquel Duarte, Madalena Duarte, et al.
Life Sciences (2024) Vol. 354, pp. 122948-122948
Open Access | Times Cited: 4
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
Jing Lu, Dilireba Shataer, Huizhen Yan, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2992-2992
Open Access | Times Cited: 4
Gut microbiome in non-alcoholic fatty liver disease
Anastasios Mpountouridis, Christina Tsigalou, Ioanna Bezirtzoglou, et al.
Frontiers in Gastroenterology (2025) Vol. 3
Open Access
Role of trans-resveratrol in ameliorating biochemical and molecular alterations in obese rats induced by a high fructose/fat diet
Mohamad Moustafa Khamis, Said S. Moselhy, Shaimaa Rihan
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lactobacillus plantarum Ameliorates High-Carbohydrate Diet-Induced Hepatic Lipid Accumulation and Oxidative Stress by Upregulating Uridine Synthesis
Rong Xu, Tong Wang, Fei-Fei Ding, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1238-1238
Open Access | Times Cited: 20
Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice
Naoshi Arai, Kouichi Miura, Kenichi Aizawa, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Ampicillin exacerbates acetaminophen‐induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction
Zhan‐Ming Li, Chao‐Yue Kong, Yuqin Mao, et al.
Liver International (2023) Vol. 43, Iss. 4, pp. 865-877
Closed Access | Times Cited: 10
Diet-Related Alterations of Gut Bile Salt Hydrolases Determined Using a Metagenomic Analysis of the Human Microbiome
Baolei Jia, Dongbin Park, Byung Hee Chun, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3652-3652
Open Access | Times Cited: 25
Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review
Valentina Castillo, Fernanda Figueroa, Karoll González-Pizarro, et al.
Foods (2021) Vol. 10, Iss. 8, pp. 1719-1719
Open Access | Times Cited: 25
Probiotics in hepatology: An update
Roman Maslennikov, В. Т. Ивашкин, Irina Efremova, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1154-1166
Open Access | Times Cited: 23
Honeysuckle Berry (Lonicera caerulea L.) Inhibits Lipase Activity and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice
Jong‐Yeon Kim, You‐Suk Lee, Eun‐Jung Park, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4731-4731
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top